A Phase II Prospective Trial of Frontline Cabozantinib in Metastatic Collecting Ducts Renal Cell Carcinoma: the BONSAI Trial (Meeturo 2)
1 Mins
Metastatic collecting ducts carcinoma is biologically poorly characterised and under-represented in prospective randomised trials.
